One of Australia’s newest biotech investment funds is set to triple investments on the back of its success and strong investor demand. The three-year old Merchant Biotech Fund (MBF) invested in several high growth ASX-listed and private life sciences companies and finished the past financial year up more than 70%. It is up 10% for the current financial year, Portfolio Manager Reece O'Connell told BioWorld.
Join us for an upcoming webinar on September 26 at 8 am PT | 10 am CT | 11 am ET that delves into the complexities of groundbreaking treatments like Pulsed Field Ablation (PFA).
The U.S. FDA announced a class I recall declared by Baxter Healthcare Corp., of Deerfield, Ill., for the automated compounding inlets used with the company’s Exactomix compounding systems due to the risk of particulate matter in the inlets.
Joe Kiani’s reign at Masimo Corp. abruptly ended following a vote at the annual shareholders meeting on Sept. 19 that saw Kiani, Masimo’s founder and CEO, ousted from the board as part of a hard-fought battle with activist investor Politan Capital Management. Michelle Brennan, a Politan nominee and former Johnson & Johnson senior executive who won her board seat last year, was named interim CEO.
The med-tech sector is at a turning point with great technologies, investors and buyers coming together to create a healthier ecosystem, Luc Marengère, managing partner at TVM Capital Life Science told BioWorld. As such, the venture capital firm has its eye on a new fund as it finalizes the portfolio for the current one.
The U.S. Court of Appeals for the Federal Circuit remanded a patent case to district court after finding that a patent applicant need not invoke identical terminology when describing a central feature of a catheter technology across multiple patents.
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carigenetics, Exthera, Flat Medical, Fujirebio, Gilero, Implantica, Injeq, Medtronic, Metabolomics, One Biomed, Sanner, Tricares, Trinity Biotech.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Human in Motion Robotics.
RSS
